Norges Bank
XERS icon

Norges Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Norges Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31M Buy
+797,200
New +$5.09M ﹤0.01% 1356
2026
Q1 		– Sell
-800,700
Closed -$6.29M – 1436
2025
Q4 		$6.29M Buy
+800,700
New +$6.3M ﹤0.01% 1353
2025
Q3 		– Sell
-561,700
Closed -$2.62M – 1601
2025
Q2 		$2.62M Sell
561,700
-262,100
-32% -$1.2M ﹤0.01% 1395
2025
Q1 		$4.52M Buy
+823,800
New +$3.33M ﹤0.01% 1379
2018
Q3 		– Sell
-15,000
Closed -$285K – 2169
2018
Q2 		$285K Buy
+15,000
New +$291K ﹤0.01% 2104

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank's XERS Position: Q2 2026 in Review

Norges Bank opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 797,200 shares worth $6.31M. The stake represents ﹤0.01% of the portfolio and ranks #1356 among its holdings. This is a return to the name: Norges Bank previously reported a position in XERS as recently as Q4 2025.

Norges Bank first reported a position in XERS in Q2 2018 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Norges Bank held 797,200 shares of Xeris Biopharma Holdings worth $6.31M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Norges Bank position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1356 holding.
  • Norges Bank first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.